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Abstract
Background: In sentinel node (SN) detection for cases of early gastric cancer, the submucosal dye
injection method appears to be more reasonable than the subserosal injection. To compare the
two injection methods, we have focused on the rate of concordance between hot nodes (HNs)
obtained from the radioisotope (RI) method and green nodes (GNs) obtained from the dye-guided
method in addition to the number and distribution of GNs detected, and the sensitivity of
metastatic detection.
Methods: The subjects of this study were 63 consecutive patients with gastric cancer (sT1–T2,
sN0, tumor diameter % 4 cm) in whom we attempted SN detection using a combination of RI and
dye methods. 99mTc-tin colloid was injected a day before the surgery, and indocyanine green was
injected either submucosally (n = 43) with endoscopes or subserosally (n = 20) by direct vision.
Results: An average of hot and green nodes (H&G: 4 ± 3 vs. 4 ± 3), hot and non-green nodes
(H&NG: 2 ± 3 vs. 1 ± 2), cold and green nodes (C&G: 2 ± 2 vs. 3 ± 4), and the rate of concordance
(H&G/H&G + H&NG + C&G: 45 + 27% vs. 48 ± 30%) were not significantly different between the
submucosal and subserosal injection methods. The spread of GNs to tier 2 stations (24% vs. 30%)
and metastatic detection sensitivity (86% vs. 100%) were also not different between the submucosal
and subserosal injection methods.
Conclusion: The tracer injection sites do not have to be limited to the submucosa.
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Background
In recent years, a number of feasibility studies for the sen-
tinel node (SN) concept in gastric cancer have been con-
ducted, and variable results have been reported [1-12]. We
have reported that SN biopsy is a useful tool for individu-
alizing surgery for early gastric cancer [12]. Most research-
ers have used colloid particles labeled with radioisotope
and/or dyes as tracers for SN detection. Radioactive tracers
must be injected endoscopically into the submucosa pre-
operatively, since radioisotopes cannot be handled out-
side of the radiation controlled area under the Japanese
law. In the dye procedure, however, there are variations in
the method in the form of submucosal injection with
endoscopes and subserosal injection of the dye agent
from the outside of the gastric wall by direct vision. When
a detection procedure is administered for cases of early
gastric cancer, submucosal injection appears to be more
reasonable, but there are no reliable comparative studies
of submucosal injection and subserosal injection for this
purpose. Injecting tracers precisely around the tumor,
which may be most important to identify true SNs, totally
depends on the skill of endoscopists in cases of submu-
cosal injection. On the other hand, subserosal injection
from the outside of the gastric wall is easy and accurate as
long as the tumor location is identified during surgery. We
have used a combination of a radio-guided method using
99mTc-labeled tin colloid and a dye-guided method using
indocyanine green (ICG) solution. 99mTc-tin colloid was
injected submucosally, and ICG solution was injected
either submucosally or subserosally. In this study, we
compared the two methods of injection, submucosal or
subserosal, focusing on the rate of concordance between
hot nodes (HNs) obtained from the RI method and green
nodes (GNs) obtained from the dye-guided method. We
have also focused on the number and distribution of GNs
detected and the metastatic detection sensitivity. Finally,
we have weighed the merits of each injection method.
Subjects and methods
The subjects of the study were 63 patients with T1-2 gastric
cancer with tumor dimension of 4 cm or less and with no
apparent lymph node metastasis in whom we attempted
the SN detection procedure through the concurrent use of
the RI and dye-guided methods during the period from
January 2003 to March 2008. Of these, ICG solution was
injected submucosally in 43 patients and subserosally in
the remaining 20 patients.
We injected 0.5 ml of 99mTc-tin colloid at each of four sites
surrounding the tumor with endoscopes a day before the
surgery. Immediately following laparotomy, we injected 4
ml of 1.25% indocyanine green solution either into the
submucosa surrounding the tumor with endoscopes or
into the subserous and muscular layers surrounding the
tumor from the outside of the stomach by direct observa-
tion. When we decided which of the two injection meth-
ods was used, we chose the one with which the tracer
would be injected more accurately around the tumor. For
example, subserosal injection from the outside of the
stomach was chosen with a tumor located on the anterior
wall of the stomach, and endoscopic submucosal injec-
tion was chosen with a tumor of the upper part of the
stomach. We employed submucosal injection with a
tumor on the lesser curvature since tracers could be
injected directly into lymphatic vessels by subserosal
injection. We avoided endoscopic submucosal injection
when it was needed to inject the tracer tangentially to the
gastric mucosa. In cases of subserosal injection with a
tumor that was not palpable, the location of the tumor
was identified by intraoperative endoscopy. Beginning 5
minutes after the injection of the dye, we dissected lymph
node stations where HNs and/or GNs were distributed as
quickly as possible. Then, we added dissection of the
remaining lymph node stations, which was required for
preoperatively planned dissection. The HNs and GNs
were detected on a back table.
The rate of concordance of HNs and GNs was calculated
as follows:
Concordance rate = H&G/(H&G + H&NG + C&G),
where H&G = the number of hot and green nodes, H&NG
= the number of hot and non-green nodes, and C&G = the
number of cold and green nodes.
All data were analyzed using the chi-square test or Mann-
Whitney U test. A p value of less than 0.05 was considered
significant. SN identification was done under the
approval of the Institutional Review Board of the National
Defense Medical College, and written informed consent
was obtained from every patient.
Results
There were no significant differences in the clinicopatho-
logical characteristics between the 43 patients who
received submucosal injection of ICG solution and the 20
patients who received subserosal injection (Table 1). No
differences were observed in the numbers of hot and
green nodes (H&G), hot and non-green nodes (H&NG),
cold and green nodes (C&G), and GNs between the two
groups of patients. The percentage of patients in whom
GNs were distributed to tier 2 stations did not differ
between the two groups either. The concordance rate of
HNs and GNs was 45 ± 27% for the cases with submu-
cosal injection and 48 ± 30% for the cases with subserosal
injection. There was no significant difference between the
two injection methods. When the 52 patients with patho-
logically T1 tumors were analyzed, no differences were
observed in clinicopathological background factors, theJournal of Experimental & Clinical Cancer Research 2008, 27:79 http://www.jeccr.com/content/27/1/79
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Table 1: Clinicopathological characteristics
Submucosal injection Subserosal injection p value
Number of patients 43 (38) 20 (14)
Age (mean ± SD) 63 ± 8 (63 ± 8) 61 ± 15 (61 ± 16) p = 0.61 (0.64)
Sex p = 0.62 (0.75)
Male 28 (27) 15 (10)
Female 15 (11) 5 (4)
Tumor size (mean ± SD) 2.8 ± 1.8 (2.7 ± 1.3) 2.8 ± 1.3 (2.6 ± 1.5) p = 0.71(0.44)
Histology p = 0.89 (0.92)
Differentiated 25 (23) 12 (8)
Undifferentiated 18 (15) 8 (6)
Depth p = 0.62 (0.98)
M1 8 6
SM 20 8
MP 4 4
SS 1 2
Lymph node metastasis
Japanese classification p = 0.46 (0.84)
N0 36 (32) 13 (11)
N1 6 (6) 6 (2)
N2 1 (0) 1 (1)
UICC classification p = 0.18 (0.69)
N0 36 (32) 13 (11)
N1 7 (6) 7 (3)
Lymphatic invasion p = 0.68 (0.91)
ly0 27 (27) 8 (8)
ly1 12 (9) 8 (4)
ly2 3 (2) 3 (1)
ly3 1 (0) 1 (1)
Surgical procedure p = 0.68 (0.72)
Partial gastrectomy 2 (1) 3 (3)
Sleeve gastrectomy 13 (12) 8 (8)
Pylorus preserving gastrectomy 6 (6) 3 (0)
Distal gastrectomy 13 (12) 6 (3)
Proximal gastrectomy 6 (5) 0 (0)
Total gastrectomy 3 (2) 0 (0)
Mean ± SD
Data for the patients with T1 tumors are shown in parentheses
Table 2: Numbers and concordance of hot and green nodes
Submucosal injection Subserosal injection p value
H & G* 4 ± 3 (4 ± 3) 4 ± 3 (4 ± 2) p = 0.78 (0.91)
H & NG* 2 ± 3 (2 ± 3) 1 ± 2 (1 ± 2) p = 0.45 (0.57)
C & G* 2 ± 2 (3 ± 3) 3 ± 4 (2 ± 4) p = 0.95 (0.37)
Concordance of HN and GN 45 ± 27% (45 ± 27%) 48 ± 30% (48 ± 30%) p = 0.42 (0.33)
GNs median, range* 5, 0–16 (5, 0–16) 6, 1–17 (6, 1–17) p = 0.55 (0.81)
N2 distribution rate% 24% (21%) 30% (25%) p = 0.62 (1)
Mean ± SD
H & G: hot and green nodes. H & NG: hot and non-green nodes. C & G: cold and green nodes. GNs: green nodes.
*Figures are numbers of hot and/or green nodes detected.
Data for the patients with T1 tumors are shown in parenthesesJournal of Experimental & Clinical Cancer Research 2008, 27:79 http://www.jeccr.com/content/27/1/79
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numbers of H&G, H&NG, and C&G, or the number and
distribution of GNs. The concordance rate was 45 ± 27%
for the 38 cases with submucosal injection and 48 ± 30%
for the 14 cases receiving serosal injection. There was also
no significant difference between the two injection meth-
ods (Tables 1, 2).
Among all subjects, 14 had lymph node metastasis, 7 of
the 43 cases (16%) with submucosal injection and 7 of
the 20 cases (35%) with subserosal injection. There was
only one patient who showed metastasis not in hot or
green nodes but in one of the cold and non-green nodes.
ICG solution was injected submucosally, but no GNs were
detected in that case (case #5 in Table 3). The remaining
13 patients with positive lymph node metastasis showed
metastasis in hot or green nodes. Thus, the sensitivity of
metastatic detection was 93% for the entire group of sub-
jects, 86% for patients with submucosal injection, and
100% for patients with serosal injection. There was no sig-
nificant difference in detection between the submucosal
and subserosal injection methods (Table 3).
Discussion
The gastric lymphatic stream is very complicated and has
been researched for a long time. It has become clear that
there are three lymphatic plexuses in the gastric wall, the
submucosal, muscular, and subserosal lymphatic plexuses
[13]. A submucosal dye injection appears to be more rea-
sonable in cases of gastric cancer with tumor invasion lim-
ited to the mucosa or submucosa. However, lymphatic
vessels are connected to each other by a communicating
branch in the gastric wall which expands vertically [13].
Thus, tracers injected subserosally may spread in the same
way as tracers injected submucosally. Subserosal injection
may enable us to inject a tracer precisely around the tumor
on the grounds that it is possible to insert a needle straight
[14]. In fact, an excellent result has been reported in the
feasibility study of the SN concept using serosal injection
of ICG solution in patients with early gastric cancer [4].
To determine which method is more efficient for SN iden-
tification using ICG solution, submucosal injection or
subserosal injection, we focused on the rate of concord-
ance between HNs and GNs, the number and distribution
of GNs detected, and the metastatic detection sensitivity.
We found no differences in these parameters between sub-
mucosal injection and subserosal injection, although it is
difficult to draw a conclusion concerning the metastatic
detection sensitivity due to small number of patients with
metastatic lymph nodes. If the more patients with positive
node are enrolled, it might be statistically significant.
Some authors were concerned that the injection site of
tracers could be inaccurate by the subserosal approach
because the primary lesion was not always palpable from
the serosal side [2]. In such nonpalpable cases, we used
endoscopy to identify the accurate location of the primary
tumor, even for subserosal dye injection. We consider
such situation is adequate due to inject tracer precisely
around the tumor.
Lee et al., comparing the subserosal with the submucosal
dye (isosulfan blue) injection method in patients with
gastric cancer, found no significant differences between
them in detection rates, the mean number of SNs, or the
sensitivity of the SN biopsies. They concluded that both
injection methods were equally efficient for SN biopsy in
patients with gastric cancer, but that the serosal injection
method was preferable due to its easy technique and short
Table 3: Lymph node metastasis according to the distribution of the tracers
H & G* H&NG* C&G* C&NG* Concordance of HN and GN Tumor depth Tumor size (mm) Histology
Submucosal injection
#1 2 (1) ND 1(0) 22 (0) 67% SM 44 Differentiated
#2 1 (0) 2 (1) ND 35 (0) 33% M 23 Differentiated
#3 3 (2) 1 (0) 2 (0) 39 (2) 60% SS 50 Differentiated
#4 11 (3) 1 (0) 1 (0) 26 (0) 85% SM 18 Undifferentiated
#5 ND 2 (0) ND 16 (1) 0% SM 25 Undifferentiated
#6 1 (1) 6 (0) 2 (0) 8 (0) 11% SM 40 Undifferentiated
#7 7 (1) 4 (0) 5 (0) 18 (0) 44% SM 22 Differentiated
Subserosal injection
#8 1 (1) 6 (0) ND 21 (0) 14% SM 18 Differentiated
#9 6 (3) 2 (0) ND 48 (2) 75% SM 11 Differentiated
#10 12 (1) 4 (0) 5 (0) 18 (0) 57% SS 22 Differentiated
#11 6 (1) 3 (0) 3 (0) 25 (1) 50% MP 45 Undifferentiated
#12 3 (1) ND 8 (1) 21 (1) 27% SS 32 Differentiated
#13 7 (4) 1 (0) 1 (0) 47 (0) 77% SM 37 Undifferentiated
#14 3 (3) ND ND 11 (0) 100% MP 45 Undifferentiated
*Figures are numbers of isolated lymph nodes with numbers of metastatic nodes in parentheses
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operation time [15]. Although their results are in accord-
ance with ours, the sensitivity of detecting node metastasis
was 45% for submucosal injection method and 61% for
subserosal injection in their study, which were considera-
bly low sensitivity rates as compared with our study and
other studies reported previously [1,2,4-8,10,12]. We
could not find any other studies that compared the two
methods, submucosal and subserosal injection of tracers,
for detecting SNs in gastric cancer. Choosing appropriate
tracers and injecting them accurately around the tumor
are essential for identifying SNs in early gastric cancer. We
conclude that tracers can be injected either submucosally
from inside or subserosally from outside of the stomach,
as long as they are injected precisely in the area surround-
ing the tumor.
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